Skip to content

Paul Po-Sheng Cheng, M.D. PH.D.

NPI 1972923878ActiveIndividual· Internal Medicine, Cardiovascular Disease· Stanford, CA

Internal Medicine, Cardiovascular Disease (M.D. PH.D.) in Stanford, California, trained at University of California, San Francisco School of Medicine (class of 2014). Their prescriptions cost Medicare Part D more than their services did: $582,413 for 765 claims, against $35,394 paid for services in 2024. Alnylam Pharmaceuticals Inc. reported $24.73 in payments in 2025, mostly food and beverage.

Overview

NPI1972923878
StatusActive
Entity typeIndividual
CredentialM.D. PH.D.
Sole proprietorNo
NPI issuedApr 18, 2014
Last updated in NPPESApr 14, 2024
Certified by providerApr 14, 2024

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Cardiovascular Disease (Cardiology) (CA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients280
Services billed429 across 18 procedure codes
Paid by Medicare$35,394

Part D prescriptions in 2024

Prescriptions (claims)765 · 1,894 30-day fills
Patients100
Total drug cost$582,413
Generic share71% of claims

Medicare sources and data years

Education and affiliations

Medical schoolUniversity of California, San Francisco School of Medicine
Graduation year2014
Medicare specialtyCardiovascular Disease (Cardiology)
Secondary specialtiesInternal Medicine
TelehealthOffers telehealth

Medical group

Hospital affiliations

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$24.73 · 1 payment from 1 company
  • 2024$78.06 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Alnylam Pharmaceuticals Inc.$24.731

What the 2025 payments were for

  • Food and Beverage$24.73 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Cardiovascular Disease providers in Stanford

All Internal Medicine, Cardiovascular Disease providers in California →